OMEPRAZOLE (20-MG DAILY) VERSUS CIMETIDINE (1200-MG DAILY) IN DUODENAL-ULCER HEALING AND PAIN RELIEF

被引:72
作者
ARCHAMBAULT, AP
PARE, P
BAILEY, RJ
NAVERT, H
WILLIAMS, CN
FREEMAN, HJ
BAKER, SJ
MARCON, NE
HUNT, RH
SUTHERLAND, L
KEPKAY, DL
SAIBIL, FG
HAWKEN, K
FARLEY, A
LEVESQUE, D
FERGUSON, J
WESTIN, JA
机构
[1] SUNNYBROOK MED CTR, DEPT GASTROENTEROL, TORONTO M4N 3M5, ONTARIO, CANADA
[2] HLTH SCI CTR, ST JOHNS, NB, CANADA
[3] ASTRA PHARM INC, MISSISSAUGA, ONTARIO, CANADA
[4] HOP MAISONNEUVE ROSEMONT, MONTREAL H1T 2M4, QUEBEC, CANADA
[5] UNIV LAVAL, HOTEL DIEU QUEBEC HOSP, DIV GASTROENTEROL, QUEBEC CITY G1K 7P4, QUEBEC, CANADA
[6] ROYAL ALEXANDRA HOSP, EDMONTON, ALBERTA, CANADA
[7] UNIV SHERBROOKE, CTR RECH PHYSIOPATHOL DIGEST, SHERBROOKE J1K 2R1, QUEBEC, CANADA
[8] DALHOUSIE UNIV, DIV GASTROENTEROL, HALIFAX B3H 4H2, NS, CANADA
[9] UNIV BRITISH COLUMBIA, HLTH SCI CTR, DIV GASTROENTEROL, VANCOUVER V6T 1W5, BC, CANADA
[10] ST BONIFACE GEN HOSP, WINNIPEG R2H 2A6, MANITOBA, CANADA
[11] WELLESLEY COLL, DEPT GASTROENTEROL, WELLESLEY, MA 02181 USA
[12] MCMASTER UNIV, MED CTR, DEPT GASTROENTEROL, HAMILTON L8S 4L8, ONTARIO, CANADA
[13] FOOTHILLS HOSP, DEPT GASTROENTEROL, CALGARY, ALBERTA, CANADA
[14] ROYAL COLUMBIAN HOSP, DEPT GASTROENTEROL, NEW WESTMINISTER, BC, CANADA
[15] ST MARYS HOSP, NEW WESTMINISTER, BC, CANADA
关键词
D O I
10.1016/0016-5085(88)90003-0
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:1130 / 1134
页数:5
相关论文
共 7 条
[1]   OMEPRAZOLE - A PRELIMINARY REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC POTENTIAL IN PEPTIC-ULCER DISEASE AND ZOLLINGER-ELLISON SYNDROME [J].
CLISSOLD, SP ;
CAMPOLIRICHARDS, DM .
DRUGS, 1986, 32 (01) :15-47
[2]  
HOWDEN CW, 1986, HEPATO-GASTROENTEROL, V33, P267
[3]   THE CORRELATION BETWEEN ACID SUPPRESSION AND PEPTIC-ULCER HEALING [J].
HUNT, RH ;
HOWDEN, CW ;
JONES, DB ;
BURGET, DW ;
KERR, GD .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1986, 21 :22-31
[4]  
JONES DB, 1987, IN PRESS GUT
[5]   EFFECT OF OMERPRAZOLE AND CIMETIDINE ON DUODENAL-ULCER - A DOUBLE-BLIND COMPARATIVE TRIAL [J].
LAURITSEN, K ;
RUNE, SJ ;
BYTZER, P ;
KELBAEK, H ;
JENSEN, KG ;
RASKMADSEN, J ;
BENDTSEN, F ;
LINDE, J ;
HOJLUND, M ;
ANDERSEN, HH ;
MOLLMANN, KM ;
NISSEN, VR ;
OVESEN, L ;
SCHLICHTING, P ;
TAGEJENSEN, U ;
WULFF, HR .
NEW ENGLAND JOURNAL OF MEDICINE, 1985, 312 (15) :958-961
[6]   DOUBLE-BLIND COMPARATIVE-STUDY OF OMEPRAZOLE 10 MG AND 30 MG DAILY FOR HEALING DUODENAL-ULCERS [J].
PRICHARD, PJ ;
RUBINSTEIN, D ;
JONES, DB ;
DUDLEY, FJ ;
SMALLWOOD, RA ;
LOUIS, WJ ;
YEOMANS, ND .
BRITISH MEDICAL JOURNAL, 1985, 290 (6468) :601-603
[7]   OPTIMAL DOSE OF ORAL OMEPRAZOLE FOR MAXIMAL 24 HOUR DECREASE OF INTRAGASTRIC ACIDITY [J].
SHARMA, BK ;
WALT, RP ;
POUNDER, RE ;
GOMES, MDA ;
WOOD, EC ;
LOGAN, LH .
GUT, 1984, 25 (09) :957-964